RBC Capital analyst issues OUTPERFORM recommendation for BKR on August 25, 2026 11:55AM ET. The previous analyst recommendation was Outperform.BKR was trading at $61.985 at issue of the analyst recommendation.The...
Raymond James analyst issues UNDERPERFORM recommendation for COP on August 24, 2026 01:27PM ET. The previous analyst recommendation was Underperform.COP was trading at $134.9 at issue of the analyst recommendation.The...
Goldman Sachs analyst issues NEUTRAL recommendation for EOG on August 24, 2026 10:09AM ET. The previous analyst recommendation was Neutral.EOG was trading at $153.05 at issue of the analyst recommendation.The...
RBC Capital analyst issues OUTPERFORM recommendation for MPLX on August 21, 2026 12:19PM ET. The previous analyst recommendation was Outperform.MPLX was trading at $58.6 at issue of the analyst recommendation.The...
Piper Sandler analyst issues OVERWEIGHT recommendation for PTEN on August 21, 2026 12:09PM ET. The previous analyst recommendation was Overweight.PTEN was trading at $12.18 at issue of the analyst recommendation.The...
Morgan Stanley analyst issues OUTPERFORM recommendation for PTEN on August 20, 2026 11:40AM ET. The previous analyst recommendation was Outperform.PTEN was trading at $12.06 at issue of the analyst recommendation.The...
Exane BNP Paribas analyst issues OUTPERFORM recommendation for CEG on August 19, 2026 04:43PM ET. The previous analyst recommendation was Outperform.CEG was trading at $271.94 at issue of the analyst...
Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for FANG on August 19, 2026 01:08PM ET. The previous analyst recommendation was Overweight.FANG was trading at $212 at issue of the analyst recommendation.The...
Morgan Stanley analyst issues OVERWEIGHT recommendation for SU on August 19, 2026 01:14PM ET. The previous analyst recommendation was Overweight.SU was trading at $68.86 at issue of the analyst recommendation.The...
Morgan Stanley analyst issues OVERWEIGHT recommendation for CVE on August 19, 2026 01:17PM ET. The previous analyst recommendation was Overweight.CVE was trading at $32.815 at issue of the analyst recommendation.The...
